nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—Irinotecan—breast cancer	0.256	1	CrCtD
Topotecan—ovarian cancer—breast cancer	0.164	1	CtDrD
Topotecan—Topoisomerase Inhibitors—Idarubicin—breast cancer	0.0847	0.279	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Irinotecan—breast cancer	0.0721	0.237	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Mitoxantrone—breast cancer	0.0721	0.237	CiPCiCtD
Topotecan—TOP1MT—Irinotecan—breast cancer	0.0469	0.358	CbGbCtD
Topotecan—ABCG2—breast cancer	0.0421	0.522	CbGaD
Topotecan—Topoisomerase Inhibitors—Epirubicin—breast cancer	0.0389	0.128	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—breast cancer	0.036	0.119	CiPCiCtD
Topotecan—TOP1—Irinotecan—breast cancer	0.0269	0.205	CbGbCtD
Topotecan—CYP3A4—breast cancer	0.021	0.261	CbGaD
Topotecan—ABCB1—breast cancer	0.0175	0.217	CbGaD
Topotecan—ABCG2—Tamoxifen—breast cancer	0.00333	0.0254	CbGbCtD
Topotecan—ABCB1—Toremifene—breast cancer	0.00328	0.025	CbGbCtD
Topotecan—ABCG2—Mitoxantrone—breast cancer	0.00324	0.0247	CbGbCtD
Topotecan—CYP3A4—Exemestane—breast cancer	0.00284	0.0216	CbGbCtD
Topotecan—ABCG2—Paclitaxel—breast cancer	0.00259	0.0197	CbGbCtD
Topotecan—ABCG2—Irinotecan—breast cancer	0.00255	0.0195	CbGbCtD
Topotecan—ABCG2—Fluorouracil—breast cancer	0.00245	0.0187	CbGbCtD
Topotecan—ABCG2—Carboplatin—breast cancer	0.00244	0.0186	CbGbCtD
Topotecan—CYP3A4—Letrozole—breast cancer	0.00241	0.0184	CbGbCtD
Topotecan—ABCB1—Lapatinib—breast cancer	0.0024	0.0183	CbGbCtD
Topotecan—CYP3A4—Anastrozole—breast cancer	0.00215	0.0164	CbGbCtD
Topotecan—CYP3A4—Toremifene—breast cancer	0.00197	0.015	CbGbCtD
Topotecan—ABCG2—Docetaxel—breast cancer	0.00187	0.0143	CbGbCtD
Topotecan—CYP3A4—Fulvestrant—breast cancer	0.00183	0.0139	CbGbCtD
Topotecan—CYP3A4—Thiotepa—breast cancer	0.00163	0.0124	CbGbCtD
Topotecan—CYP3A4—Ixabepilone—breast cancer	0.00149	0.0114	CbGbCtD
Topotecan—CYP3A4—Lapatinib—breast cancer	0.00144	0.0109	CbGbCtD
Topotecan—ABCG2—Doxorubicin—breast cancer	0.0014	0.0106	CbGbCtD
Topotecan—ABCG2—Methotrexate—breast cancer	0.00135	0.0103	CbGbCtD
Topotecan—ABCB1—Vinorelbine—breast cancer	0.00133	0.0101	CbGbCtD
Topotecan—ABCB1—Tamoxifen—breast cancer	0.0012	0.00915	CbGbCtD
Topotecan—ABCB1—Mitoxantrone—breast cancer	0.00117	0.00892	CbGbCtD
Topotecan—CYP3A4—Raloxifene—breast cancer	0.00109	0.00829	CbGbCtD
Topotecan—ABCB1—Gemcitabine—breast cancer	0.00103	0.00788	CbGbCtD
Topotecan—ABCB1—Paclitaxel—breast cancer	0.000934	0.00712	CbGbCtD
Topotecan—ABCB1—Irinotecan—breast cancer	0.000921	0.00702	CbGbCtD
Topotecan—ABCB1—Vinblastine—breast cancer	0.000819	0.00624	CbGbCtD
Topotecan—CYP3A4—Vinorelbine—breast cancer	0.000796	0.00607	CbGbCtD
Topotecan—CYP3A4—Tamoxifen—breast cancer	0.000719	0.00548	CbGbCtD
Topotecan—CYP3A4—Mitoxantrone—breast cancer	0.000701	0.00534	CbGbCtD
Topotecan—ABCB1—Docetaxel—breast cancer	0.000675	0.00515	CbGbCtD
Topotecan—TOP1—mammary gland—breast cancer	0.000603	0.0861	CbGeAlD
Topotecan—CYP3A4—Paclitaxel—breast cancer	0.000559	0.00427	CbGbCtD
Topotecan—CYP3A4—Irinotecan—breast cancer	0.000552	0.00421	CbGbCtD
Topotecan—TOP1MT—adipose tissue—breast cancer	0.000514	0.0735	CbGeAlD
Topotecan—ABCB1—Doxorubicin—breast cancer	0.000503	0.00384	CbGbCtD
Topotecan—TOP1—nipple—breast cancer	0.000499	0.0712	CbGeAlD
Topotecan—CYP3A4—Vinblastine—breast cancer	0.000491	0.00374	CbGbCtD
Topotecan—ABCB1—Methotrexate—breast cancer	0.000487	0.00372	CbGbCtD
Topotecan—TOP1MT—female reproductive system—breast cancer	0.000473	0.0675	CbGeAlD
Topotecan—TOP1MT—adrenal gland—breast cancer	0.000461	0.0659	CbGeAlD
Topotecan—TOP1MT—female gonad—breast cancer	0.00043	0.0615	CbGeAlD
Topotecan—CYP3A4—Docetaxel—breast cancer	0.000404	0.00308	CbGbCtD
Topotecan—TOP1MT—endocrine gland—breast cancer	0.0004	0.0571	CbGeAlD
Topotecan—CYP3A4—Doxorubicin—breast cancer	0.000301	0.0023	CbGbCtD
Topotecan—TOP1—endometrium—breast cancer	0.000301	0.043	CbGeAlD
Topotecan—TOP1—uterus—breast cancer	0.000277	0.0396	CbGeAlD
Topotecan—Irinotecan—SLCO1B1—breast cancer	0.000277	0.244	CrCbGaD
Topotecan—TOP1MT—lymph node—breast cancer	0.000277	0.0395	CbGeAlD
Topotecan—TOP1—pituitary gland—breast cancer	0.000272	0.0389	CbGeAlD
Topotecan—TOP1—adipose tissue—breast cancer	0.000271	0.0388	CbGeAlD
Topotecan—TOP1—adrenal gland—breast cancer	0.000243	0.0348	CbGeAlD
Topotecan—TOP1—bone marrow—breast cancer	0.000235	0.0336	CbGeAlD
Topotecan—Irinotecan—ABCC1—breast cancer	0.000229	0.201	CrCbGaD
Topotecan—TOP1—female gonad—breast cancer	0.000227	0.0324	CbGeAlD
Topotecan—Irinotecan—ACHE—breast cancer	0.000218	0.192	CrCbGaD
Topotecan—TOP1—lymph node—breast cancer	0.000146	0.0208	CbGeAlD
Topotecan—Irinotecan—BCHE—breast cancer	0.000128	0.113	CrCbGaD
Topotecan—Irinotecan—ABCG2—breast cancer	0.000121	0.106	CrCbGaD
Topotecan—ABCG2—endometrium—breast cancer	0.000107	0.0153	CbGeAlD
Topotecan—ABCG2—uterus—breast cancer	9.84e-05	0.0141	CbGeAlD
Topotecan—ABCG2—pituitary gland—breast cancer	9.66e-05	0.0138	CbGeAlD
Topotecan—ABCG2—adipose tissue—breast cancer	9.63e-05	0.0138	CbGeAlD
Topotecan—ABCG2—adrenal gland—breast cancer	8.63e-05	0.0123	CbGeAlD
Topotecan—ABCG2—bone marrow—breast cancer	8.35e-05	0.0119	CbGeAlD
Topotecan—ABCG2—female gonad—breast cancer	8.05e-05	0.0115	CbGeAlD
Topotecan—ABCB1—embryo—breast cancer	7.2e-05	0.0103	CbGeAlD
Topotecan—CYP3A4—female reproductive system—breast cancer	6.16e-05	0.0088	CbGeAlD
Topotecan—Irinotecan—CYP3A4—breast cancer	6.03e-05	0.0531	CrCbGaD
Topotecan—ABCB1—epithelium—breast cancer	5.87e-05	0.00839	CbGeAlD
Topotecan—ABCB1—endometrium—breast cancer	5.27e-05	0.00752	CbGeAlD
Topotecan—Irinotecan—ALB—breast cancer	5.26e-05	0.0463	CrCbGaD
Topotecan—CYP3A4—endocrine gland—breast cancer	5.22e-05	0.00745	CbGeAlD
Topotecan—ABCG2—lymph node—breast cancer	5.18e-05	0.00739	CbGeAlD
Topotecan—Irinotecan—ABCB1—breast cancer	5.02e-05	0.0442	CrCbGaD
Topotecan—ABCB1—uterus—breast cancer	4.85e-05	0.00693	CbGeAlD
Topotecan—ABCB1—pituitary gland—breast cancer	4.77e-05	0.00681	CbGeAlD
Topotecan—ABCB1—adipose tissue—breast cancer	4.75e-05	0.00678	CbGeAlD
Topotecan—ABCB1—female reproductive system—breast cancer	4.36e-05	0.00623	CbGeAlD
Topotecan—ABCB1—adrenal gland—breast cancer	4.26e-05	0.00608	CbGeAlD
Topotecan—ABCB1—bone marrow—breast cancer	4.12e-05	0.00588	CbGeAlD
Topotecan—ABCB1—female gonad—breast cancer	3.97e-05	0.00567	CbGeAlD
Topotecan—ABCB1—endocrine gland—breast cancer	3.69e-05	0.00527	CbGeAlD
Topotecan—ABCB1—lymph node—breast cancer	2.55e-05	0.00365	CbGeAlD
Topotecan—Infection—Capecitabine—breast cancer	7.95e-06	0.000187	CcSEcCtD
Topotecan—Neuropathy peripheral—Doxorubicin—breast cancer	7.92e-06	0.000186	CcSEcCtD
Topotecan—Dizziness—Irinotecan—breast cancer	7.9e-06	0.000186	CcSEcCtD
Topotecan—Haemoglobin—Epirubicin—breast cancer	7.88e-06	0.000185	CcSEcCtD
Topotecan—Stomatitis—Doxorubicin—breast cancer	7.88e-06	0.000185	CcSEcCtD
Topotecan—Anorexia—Docetaxel—breast cancer	7.87e-06	0.000185	CcSEcCtD
Topotecan—Rhinitis—Epirubicin—breast cancer	7.86e-06	0.000185	CcSEcCtD
Topotecan—Nervous system disorder—Capecitabine—breast cancer	7.84e-06	0.000185	CcSEcCtD
Topotecan—Haemorrhage—Epirubicin—breast cancer	7.84e-06	0.000185	CcSEcCtD
Topotecan—Diarrhoea—Fluorouracil—breast cancer	7.83e-06	0.000184	CcSEcCtD
Topotecan—Thrombocytopenia—Capecitabine—breast cancer	7.83e-06	0.000184	CcSEcCtD
Topotecan—Hypoaesthesia—Epirubicin—breast cancer	7.8e-06	0.000184	CcSEcCtD
Topotecan—Pharyngitis—Epirubicin—breast cancer	7.78e-06	0.000183	CcSEcCtD
Topotecan—Skin disorder—Capecitabine—breast cancer	7.77e-06	0.000183	CcSEcCtD
Topotecan—Sweating—Doxorubicin—breast cancer	7.75e-06	0.000182	CcSEcCtD
Topotecan—Urticaria—Paclitaxel—breast cancer	7.74e-06	0.000182	CcSEcCtD
Topotecan—Hyperhidrosis—Capecitabine—breast cancer	7.73e-06	0.000182	CcSEcCtD
Topotecan—Body temperature increased—Paclitaxel—breast cancer	7.71e-06	0.000181	CcSEcCtD
Topotecan—Abdominal pain—Paclitaxel—breast cancer	7.71e-06	0.000181	CcSEcCtD
Topotecan—Hepatobiliary disease—Doxorubicin—breast cancer	7.65e-06	0.00018	CcSEcCtD
Topotecan—Epistaxis—Doxorubicin—breast cancer	7.63e-06	0.000179	CcSEcCtD
Topotecan—Anorexia—Capecitabine—breast cancer	7.62e-06	0.000179	CcSEcCtD
Topotecan—Angiopathy—Methotrexate—breast cancer	7.6e-06	0.000179	CcSEcCtD
Topotecan—Vomiting—Mitoxantrone—breast cancer	7.6e-06	0.000179	CcSEcCtD
Topotecan—Vomiting—Irinotecan—breast cancer	7.6e-06	0.000179	CcSEcCtD
Topotecan—Immune system disorder—Methotrexate—breast cancer	7.57e-06	0.000178	CcSEcCtD
Topotecan—Dizziness—Fluorouracil—breast cancer	7.57e-06	0.000178	CcSEcCtD
Topotecan—Mediastinal disorder—Methotrexate—breast cancer	7.55e-06	0.000178	CcSEcCtD
Topotecan—Rash—Irinotecan—breast cancer	7.54e-06	0.000177	CcSEcCtD
Topotecan—Rash—Mitoxantrone—breast cancer	7.54e-06	0.000177	CcSEcCtD
Topotecan—Dermatitis—Mitoxantrone—breast cancer	7.53e-06	0.000177	CcSEcCtD
Topotecan—Dermatitis—Irinotecan—breast cancer	7.53e-06	0.000177	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Docetaxel—breast cancer	7.53e-06	0.000177	CcSEcCtD
Topotecan—Chills—Methotrexate—breast cancer	7.52e-06	0.000177	CcSEcCtD
Topotecan—Headache—Mitoxantrone—breast cancer	7.49e-06	0.000176	CcSEcCtD
Topotecan—Headache—Irinotecan—breast cancer	7.49e-06	0.000176	CcSEcCtD
Topotecan—Paraesthesia—Docetaxel—breast cancer	7.42e-06	0.000175	CcSEcCtD
Topotecan—Alopecia—Methotrexate—breast cancer	7.41e-06	0.000174	CcSEcCtD
Topotecan—Vomiting—Gemcitabine—breast cancer	7.4e-06	0.000174	CcSEcCtD
Topotecan—Dyspnoea—Docetaxel—breast cancer	7.37e-06	0.000173	CcSEcCtD
Topotecan—Rash—Gemcitabine—breast cancer	7.34e-06	0.000173	CcSEcCtD
Topotecan—Dermatitis—Gemcitabine—breast cancer	7.33e-06	0.000173	CcSEcCtD
Topotecan—Malnutrition—Methotrexate—breast cancer	7.3e-06	0.000172	CcSEcCtD
Topotecan—Haemoglobin—Doxorubicin—breast cancer	7.29e-06	0.000172	CcSEcCtD
Topotecan—Headache—Gemcitabine—breast cancer	7.29e-06	0.000172	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Capecitabine—breast cancer	7.29e-06	0.000171	CcSEcCtD
Topotecan—Vomiting—Fluorouracil—breast cancer	7.28e-06	0.000171	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—breast cancer	7.28e-06	0.000171	CcSEcCtD
Topotecan—Dyspepsia—Docetaxel—breast cancer	7.27e-06	0.000171	CcSEcCtD
Topotecan—Haemorrhage—Doxorubicin—breast cancer	7.26e-06	0.000171	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—breast cancer	7.22e-06	0.00017	CcSEcCtD
Topotecan—Rash—Fluorouracil—breast cancer	7.22e-06	0.00017	CcSEcCtD
Topotecan—Dermatitis—Fluorouracil—breast cancer	7.21e-06	0.00017	CcSEcCtD
Topotecan—Pharyngitis—Doxorubicin—breast cancer	7.2e-06	0.000169	CcSEcCtD
Topotecan—Paraesthesia—Capecitabine—breast cancer	7.18e-06	0.000169	CcSEcCtD
Topotecan—Decreased appetite—Docetaxel—breast cancer	7.18e-06	0.000169	CcSEcCtD
Topotecan—Hypersensitivity—Paclitaxel—breast cancer	7.18e-06	0.000169	CcSEcCtD
Topotecan—Headache—Fluorouracil—breast cancer	7.17e-06	0.000169	CcSEcCtD
Topotecan—Gastrointestinal disorder—Docetaxel—breast cancer	7.13e-06	0.000168	CcSEcCtD
Topotecan—Dyspnoea—Capecitabine—breast cancer	7.13e-06	0.000168	CcSEcCtD
Topotecan—Fatigue—Docetaxel—breast cancer	7.12e-06	0.000168	CcSEcCtD
Topotecan—Angiopathy—Epirubicin—breast cancer	7.12e-06	0.000167	CcSEcCtD
Topotecan—Nausea—Mitoxantrone—breast cancer	7.1e-06	0.000167	CcSEcCtD
Topotecan—Nausea—Irinotecan—breast cancer	7.1e-06	0.000167	CcSEcCtD
Topotecan—Immune system disorder—Epirubicin—breast cancer	7.08e-06	0.000167	CcSEcCtD
Topotecan—Mediastinal disorder—Epirubicin—breast cancer	7.07e-06	0.000166	CcSEcCtD
Topotecan—Constipation—Docetaxel—breast cancer	7.06e-06	0.000166	CcSEcCtD
Topotecan—Pain—Docetaxel—breast cancer	7.06e-06	0.000166	CcSEcCtD
Topotecan—Back pain—Methotrexate—breast cancer	7.06e-06	0.000166	CcSEcCtD
Topotecan—Dyspepsia—Capecitabine—breast cancer	7.04e-06	0.000166	CcSEcCtD
Topotecan—Chills—Epirubicin—breast cancer	7.04e-06	0.000166	CcSEcCtD
Topotecan—Asthenia—Paclitaxel—breast cancer	6.99e-06	0.000165	CcSEcCtD
Topotecan—Decreased appetite—Capecitabine—breast cancer	6.95e-06	0.000164	CcSEcCtD
Topotecan—Alopecia—Epirubicin—breast cancer	6.93e-06	0.000163	CcSEcCtD
Topotecan—Nausea—Gemcitabine—breast cancer	6.91e-06	0.000163	CcSEcCtD
Topotecan—Gastrointestinal disorder—Capecitabine—breast cancer	6.91e-06	0.000162	CcSEcCtD
Topotecan—Fatigue—Capecitabine—breast cancer	6.9e-06	0.000162	CcSEcCtD
Topotecan—Pruritus—Paclitaxel—breast cancer	6.9e-06	0.000162	CcSEcCtD
Topotecan—Constipation—Capecitabine—breast cancer	6.84e-06	0.000161	CcSEcCtD
Topotecan—Pain—Capecitabine—breast cancer	6.84e-06	0.000161	CcSEcCtD
Topotecan—Malnutrition—Epirubicin—breast cancer	6.83e-06	0.000161	CcSEcCtD
Topotecan—Feeling abnormal—Docetaxel—breast cancer	6.81e-06	0.00016	CcSEcCtD
Topotecan—Nausea—Fluorouracil—breast cancer	6.8e-06	0.00016	CcSEcCtD
Topotecan—Ill-defined disorder—Methotrexate—breast cancer	6.77e-06	0.000159	CcSEcCtD
Topotecan—Gastrointestinal pain—Docetaxel—breast cancer	6.76e-06	0.000159	CcSEcCtD
Topotecan—Anaemia—Methotrexate—breast cancer	6.74e-06	0.000159	CcSEcCtD
Topotecan—Diarrhoea—Paclitaxel—breast cancer	6.67e-06	0.000157	CcSEcCtD
Topotecan—Back pain—Epirubicin—breast cancer	6.6e-06	0.000155	CcSEcCtD
Topotecan—Feeling abnormal—Capecitabine—breast cancer	6.59e-06	0.000155	CcSEcCtD
Topotecan—Angiopathy—Doxorubicin—breast cancer	6.58e-06	0.000155	CcSEcCtD
Topotecan—Malaise—Methotrexate—breast cancer	6.58e-06	0.000155	CcSEcCtD
Topotecan—Muscle spasms—Epirubicin—breast cancer	6.56e-06	0.000154	CcSEcCtD
Topotecan—Immune system disorder—Doxorubicin—breast cancer	6.56e-06	0.000154	CcSEcCtD
Topotecan—Gastrointestinal pain—Capecitabine—breast cancer	6.54e-06	0.000154	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—breast cancer	6.54e-06	0.000154	CcSEcCtD
Topotecan—Body temperature increased—Docetaxel—breast cancer	6.53e-06	0.000154	CcSEcCtD
Topotecan—Abdominal pain—Docetaxel—breast cancer	6.53e-06	0.000154	CcSEcCtD
Topotecan—Leukopenia—Methotrexate—breast cancer	6.53e-06	0.000154	CcSEcCtD
Topotecan—Chills—Doxorubicin—breast cancer	6.51e-06	0.000153	CcSEcCtD
Topotecan—Dizziness—Paclitaxel—breast cancer	6.45e-06	0.000152	CcSEcCtD
Topotecan—Alopecia—Doxorubicin—breast cancer	6.41e-06	0.000151	CcSEcCtD
Topotecan—Cough—Methotrexate—breast cancer	6.37e-06	0.00015	CcSEcCtD
Topotecan—Urticaria—Capecitabine—breast cancer	6.35e-06	0.00015	CcSEcCtD
Topotecan—Ill-defined disorder—Epirubicin—breast cancer	6.33e-06	0.000149	CcSEcCtD
Topotecan—Abdominal pain—Capecitabine—breast cancer	6.32e-06	0.000149	CcSEcCtD
Topotecan—Body temperature increased—Capecitabine—breast cancer	6.32e-06	0.000149	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—breast cancer	6.32e-06	0.000149	CcSEcCtD
Topotecan—Anaemia—Epirubicin—breast cancer	6.31e-06	0.000148	CcSEcCtD
Topotecan—Chest pain—Methotrexate—breast cancer	6.21e-06	0.000146	CcSEcCtD
Topotecan—Myalgia—Methotrexate—breast cancer	6.21e-06	0.000146	CcSEcCtD
Topotecan—Arthralgia—Methotrexate—breast cancer	6.21e-06	0.000146	CcSEcCtD
Topotecan—Vomiting—Paclitaxel—breast cancer	6.2e-06	0.000146	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.17e-06	0.000145	CcSEcCtD
Topotecan—Malaise—Epirubicin—breast cancer	6.16e-06	0.000145	CcSEcCtD
Topotecan—Rash—Paclitaxel—breast cancer	6.15e-06	0.000145	CcSEcCtD
Topotecan—Dermatitis—Paclitaxel—breast cancer	6.14e-06	0.000144	CcSEcCtD
Topotecan—Discomfort—Methotrexate—breast cancer	6.14e-06	0.000144	CcSEcCtD
Topotecan—Leukopenia—Epirubicin—breast cancer	6.11e-06	0.000144	CcSEcCtD
Topotecan—Back pain—Doxorubicin—breast cancer	6.11e-06	0.000144	CcSEcCtD
Topotecan—Headache—Paclitaxel—breast cancer	6.11e-06	0.000144	CcSEcCtD
Topotecan—Hypersensitivity—Docetaxel—breast cancer	6.09e-06	0.000143	CcSEcCtD
Topotecan—Muscle spasms—Doxorubicin—breast cancer	6.07e-06	0.000143	CcSEcCtD
Topotecan—Cough—Epirubicin—breast cancer	5.96e-06	0.00014	CcSEcCtD
Topotecan—Anaphylactic shock—Methotrexate—breast cancer	5.95e-06	0.00014	CcSEcCtD
Topotecan—Asthenia—Docetaxel—breast cancer	5.93e-06	0.000139	CcSEcCtD
Topotecan—Infection—Methotrexate—breast cancer	5.92e-06	0.000139	CcSEcCtD
Topotecan—Hypersensitivity—Capecitabine—breast cancer	5.89e-06	0.000139	CcSEcCtD
Topotecan—Ill-defined disorder—Doxorubicin—breast cancer	5.86e-06	0.000138	CcSEcCtD
Topotecan—Pruritus—Docetaxel—breast cancer	5.84e-06	0.000138	CcSEcCtD
Topotecan—Nervous system disorder—Methotrexate—breast cancer	5.84e-06	0.000137	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—breast cancer	5.84e-06	0.000137	CcSEcCtD
Topotecan—Thrombocytopenia—Methotrexate—breast cancer	5.83e-06	0.000137	CcSEcCtD
Topotecan—Chest pain—Epirubicin—breast cancer	5.81e-06	0.000137	CcSEcCtD
Topotecan—Myalgia—Epirubicin—breast cancer	5.81e-06	0.000137	CcSEcCtD
Topotecan—Arthralgia—Epirubicin—breast cancer	5.81e-06	0.000137	CcSEcCtD
Topotecan—Nausea—Paclitaxel—breast cancer	5.79e-06	0.000136	CcSEcCtD
Topotecan—Skin disorder—Methotrexate—breast cancer	5.78e-06	0.000136	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.77e-06	0.000136	CcSEcCtD
Topotecan—Hyperhidrosis—Methotrexate—breast cancer	5.76e-06	0.000135	CcSEcCtD
Topotecan—Discomfort—Epirubicin—breast cancer	5.74e-06	0.000135	CcSEcCtD
Topotecan—Asthenia—Capecitabine—breast cancer	5.74e-06	0.000135	CcSEcCtD
Topotecan—Malaise—Doxorubicin—breast cancer	5.7e-06	0.000134	CcSEcCtD
Topotecan—Anorexia—Methotrexate—breast cancer	5.68e-06	0.000134	CcSEcCtD
Topotecan—Pruritus—Capecitabine—breast cancer	5.66e-06	0.000133	CcSEcCtD
Topotecan—Leukopenia—Doxorubicin—breast cancer	5.65e-06	0.000133	CcSEcCtD
Topotecan—Diarrhoea—Docetaxel—breast cancer	5.65e-06	0.000133	CcSEcCtD
Topotecan—Anaphylactic shock—Epirubicin—breast cancer	5.57e-06	0.000131	CcSEcCtD
Topotecan—Infection—Epirubicin—breast cancer	5.54e-06	0.00013	CcSEcCtD
Topotecan—Cough—Doxorubicin—breast cancer	5.51e-06	0.00013	CcSEcCtD
Topotecan—Diarrhoea—Capecitabine—breast cancer	5.47e-06	0.000129	CcSEcCtD
Topotecan—Nervous system disorder—Epirubicin—breast cancer	5.46e-06	0.000129	CcSEcCtD
Topotecan—Dizziness—Docetaxel—breast cancer	5.46e-06	0.000129	CcSEcCtD
Topotecan—Thrombocytopenia—Epirubicin—breast cancer	5.46e-06	0.000128	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Methotrexate—breast cancer	5.42e-06	0.000128	CcSEcCtD
Topotecan—Skin disorder—Epirubicin—breast cancer	5.41e-06	0.000127	CcSEcCtD
Topotecan—Hyperhidrosis—Epirubicin—breast cancer	5.39e-06	0.000127	CcSEcCtD
Topotecan—Chest pain—Doxorubicin—breast cancer	5.38e-06	0.000127	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—breast cancer	5.38e-06	0.000127	CcSEcCtD
Topotecan—Arthralgia—Doxorubicin—breast cancer	5.38e-06	0.000127	CcSEcCtD
Topotecan—Paraesthesia—Methotrexate—breast cancer	5.35e-06	0.000126	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.34e-06	0.000126	CcSEcCtD
Topotecan—Discomfort—Doxorubicin—breast cancer	5.31e-06	0.000125	CcSEcCtD
Topotecan—Anorexia—Epirubicin—breast cancer	5.31e-06	0.000125	CcSEcCtD
Topotecan—Dyspnoea—Methotrexate—breast cancer	5.31e-06	0.000125	CcSEcCtD
Topotecan—Dizziness—Capecitabine—breast cancer	5.29e-06	0.000124	CcSEcCtD
Topotecan—Vomiting—Docetaxel—breast cancer	5.25e-06	0.000124	CcSEcCtD
Topotecan—Dyspepsia—Methotrexate—breast cancer	5.24e-06	0.000123	CcSEcCtD
Topotecan—Rash—Docetaxel—breast cancer	5.21e-06	0.000123	CcSEcCtD
Topotecan—Dermatitis—Docetaxel—breast cancer	5.2e-06	0.000122	CcSEcCtD
Topotecan—Decreased appetite—Methotrexate—breast cancer	5.18e-06	0.000122	CcSEcCtD
Topotecan—Headache—Docetaxel—breast cancer	5.18e-06	0.000122	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—breast cancer	5.16e-06	0.000121	CcSEcCtD
Topotecan—Gastrointestinal disorder—Methotrexate—breast cancer	5.14e-06	0.000121	CcSEcCtD
Topotecan—Fatigue—Methotrexate—breast cancer	5.13e-06	0.000121	CcSEcCtD
Topotecan—Infection—Doxorubicin—breast cancer	5.12e-06	0.000121	CcSEcCtD
Topotecan—Pain—Methotrexate—breast cancer	5.09e-06	0.00012	CcSEcCtD
Topotecan—Vomiting—Capecitabine—breast cancer	5.09e-06	0.00012	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Epirubicin—breast cancer	5.08e-06	0.000119	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—breast cancer	5.06e-06	0.000119	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—breast cancer	5.05e-06	0.000119	CcSEcCtD
Topotecan—Rash—Capecitabine—breast cancer	5.04e-06	0.000119	CcSEcCtD
Topotecan—Dermatitis—Capecitabine—breast cancer	5.04e-06	0.000119	CcSEcCtD
Topotecan—Headache—Capecitabine—breast cancer	5.01e-06	0.000118	CcSEcCtD
Topotecan—Skin disorder—Doxorubicin—breast cancer	5.01e-06	0.000118	CcSEcCtD
Topotecan—Paraesthesia—Epirubicin—breast cancer	5e-06	0.000118	CcSEcCtD
Topotecan—Hyperhidrosis—Doxorubicin—breast cancer	4.98e-06	0.000117	CcSEcCtD
Topotecan—Dyspnoea—Epirubicin—breast cancer	4.97e-06	0.000117	CcSEcCtD
Topotecan—Anorexia—Doxorubicin—breast cancer	4.91e-06	0.000116	CcSEcCtD
Topotecan—Nausea—Docetaxel—breast cancer	4.91e-06	0.000115	CcSEcCtD
Topotecan—Feeling abnormal—Methotrexate—breast cancer	4.91e-06	0.000115	CcSEcCtD
Topotecan—Dyspepsia—Epirubicin—breast cancer	4.91e-06	0.000115	CcSEcCtD
Topotecan—Gastrointestinal pain—Methotrexate—breast cancer	4.87e-06	0.000115	CcSEcCtD
Topotecan—Decreased appetite—Epirubicin—breast cancer	4.84e-06	0.000114	CcSEcCtD
Topotecan—Gastrointestinal disorder—Epirubicin—breast cancer	4.81e-06	0.000113	CcSEcCtD
Topotecan—Fatigue—Epirubicin—breast cancer	4.8e-06	0.000113	CcSEcCtD
Topotecan—Constipation—Epirubicin—breast cancer	4.77e-06	0.000112	CcSEcCtD
Topotecan—Pain—Epirubicin—breast cancer	4.77e-06	0.000112	CcSEcCtD
Topotecan—Nausea—Capecitabine—breast cancer	4.75e-06	0.000112	CcSEcCtD
Topotecan—Urticaria—Methotrexate—breast cancer	4.73e-06	0.000111	CcSEcCtD
Topotecan—Abdominal pain—Methotrexate—breast cancer	4.71e-06	0.000111	CcSEcCtD
Topotecan—Body temperature increased—Methotrexate—breast cancer	4.71e-06	0.000111	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.7e-06	0.000111	CcSEcCtD
Topotecan—Paraesthesia—Doxorubicin—breast cancer	4.63e-06	0.000109	CcSEcCtD
Topotecan—Dyspnoea—Doxorubicin—breast cancer	4.6e-06	0.000108	CcSEcCtD
Topotecan—Feeling abnormal—Epirubicin—breast cancer	4.59e-06	0.000108	CcSEcCtD
Topotecan—Gastrointestinal pain—Epirubicin—breast cancer	4.56e-06	0.000107	CcSEcCtD
Topotecan—Dyspepsia—Doxorubicin—breast cancer	4.54e-06	0.000107	CcSEcCtD
Topotecan—Decreased appetite—Doxorubicin—breast cancer	4.48e-06	0.000105	CcSEcCtD
Topotecan—Gastrointestinal disorder—Doxorubicin—breast cancer	4.45e-06	0.000105	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—breast cancer	4.45e-06	0.000105	CcSEcCtD
Topotecan—Urticaria—Epirubicin—breast cancer	4.43e-06	0.000104	CcSEcCtD
Topotecan—Pain—Doxorubicin—breast cancer	4.41e-06	0.000104	CcSEcCtD
Topotecan—Constipation—Doxorubicin—breast cancer	4.41e-06	0.000104	CcSEcCtD
Topotecan—Body temperature increased—Epirubicin—breast cancer	4.41e-06	0.000104	CcSEcCtD
Topotecan—Abdominal pain—Epirubicin—breast cancer	4.41e-06	0.000104	CcSEcCtD
Topotecan—Hypersensitivity—Methotrexate—breast cancer	4.39e-06	0.000103	CcSEcCtD
Topotecan—Asthenia—Methotrexate—breast cancer	4.27e-06	0.000101	CcSEcCtD
Topotecan—Feeling abnormal—Doxorubicin—breast cancer	4.25e-06	0.0001	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—breast cancer	4.22e-06	9.92e-05	CcSEcCtD
Topotecan—Pruritus—Methotrexate—breast cancer	4.21e-06	9.91e-05	CcSEcCtD
Topotecan—Hypersensitivity—Epirubicin—breast cancer	4.11e-06	9.66e-05	CcSEcCtD
Topotecan—Urticaria—Doxorubicin—breast cancer	4.1e-06	9.64e-05	CcSEcCtD
Topotecan—Abdominal pain—Doxorubicin—breast cancer	4.08e-06	9.59e-05	CcSEcCtD
Topotecan—Body temperature increased—Doxorubicin—breast cancer	4.08e-06	9.59e-05	CcSEcCtD
Topotecan—Diarrhoea—Methotrexate—breast cancer	4.07e-06	9.59e-05	CcSEcCtD
Topotecan—Asthenia—Epirubicin—breast cancer	4e-06	9.41e-05	CcSEcCtD
Topotecan—Pruritus—Epirubicin—breast cancer	3.94e-06	9.28e-05	CcSEcCtD
Topotecan—Dizziness—Methotrexate—breast cancer	3.94e-06	9.26e-05	CcSEcCtD
Topotecan—Diarrhoea—Epirubicin—breast cancer	3.81e-06	8.97e-05	CcSEcCtD
Topotecan—Hypersensitivity—Doxorubicin—breast cancer	3.8e-06	8.94e-05	CcSEcCtD
Topotecan—Vomiting—Methotrexate—breast cancer	3.79e-06	8.91e-05	CcSEcCtD
Topotecan—Rash—Methotrexate—breast cancer	3.75e-06	8.83e-05	CcSEcCtD
Topotecan—Dermatitis—Methotrexate—breast cancer	3.75e-06	8.82e-05	CcSEcCtD
Topotecan—Headache—Methotrexate—breast cancer	3.73e-06	8.78e-05	CcSEcCtD
Topotecan—Asthenia—Doxorubicin—breast cancer	3.7e-06	8.7e-05	CcSEcCtD
Topotecan—Dizziness—Epirubicin—breast cancer	3.68e-06	8.67e-05	CcSEcCtD
Topotecan—Pruritus—Doxorubicin—breast cancer	3.65e-06	8.58e-05	CcSEcCtD
Topotecan—Vomiting—Epirubicin—breast cancer	3.54e-06	8.34e-05	CcSEcCtD
Topotecan—Nausea—Methotrexate—breast cancer	3.54e-06	8.32e-05	CcSEcCtD
Topotecan—Diarrhoea—Doxorubicin—breast cancer	3.53e-06	8.3e-05	CcSEcCtD
Topotecan—Rash—Epirubicin—breast cancer	3.51e-06	8.27e-05	CcSEcCtD
Topotecan—Dermatitis—Epirubicin—breast cancer	3.51e-06	8.26e-05	CcSEcCtD
Topotecan—Headache—Epirubicin—breast cancer	3.49e-06	8.21e-05	CcSEcCtD
Topotecan—Dizziness—Doxorubicin—breast cancer	3.41e-06	8.02e-05	CcSEcCtD
Topotecan—Nausea—Epirubicin—breast cancer	3.31e-06	7.79e-05	CcSEcCtD
Topotecan—Vomiting—Doxorubicin—breast cancer	3.28e-06	7.71e-05	CcSEcCtD
Topotecan—Rash—Doxorubicin—breast cancer	3.25e-06	7.65e-05	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—breast cancer	3.25e-06	7.64e-05	CcSEcCtD
Topotecan—Headache—Doxorubicin—breast cancer	3.23e-06	7.6e-05	CcSEcCtD
Topotecan—Nausea—Doxorubicin—breast cancer	3.06e-06	7.21e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—DPYD—breast cancer	2.7e-06	0.000189	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC2A5—breast cancer	2.68e-06	0.000187	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLCO1B1—breast cancer	2.68e-06	0.000187	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALDOA—breast cancer	2.66e-06	0.000186	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	2.63e-06	0.000184	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	2.59e-06	0.000181	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APRT—breast cancer	2.59e-06	0.000181	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	2.59e-06	0.000181	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOA3—breast cancer	2.58e-06	0.000181	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	2.58e-06	0.000181	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC2A2—breast cancer	2.57e-06	0.00018	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	2.55e-06	0.000179	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CPT1A—breast cancer	2.51e-06	0.000176	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTR—breast cancer	2.51e-06	0.000176	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	2.5e-06	0.000175	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	2.49e-06	0.000174	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HPGDS—breast cancer	2.47e-06	0.000173	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HBA1—breast cancer	2.45e-06	0.000171	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ESRRA—breast cancer	2.43e-06	0.00017	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ANGPTL4—breast cancer	2.43e-06	0.00017	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ACHE—breast cancer	2.39e-06	0.000167	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTT1—breast cancer	2.39e-06	0.000167	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.38e-06	0.000166	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	2.36e-06	0.000165	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	2.32e-06	0.000162	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPI—breast cancer	2.31e-06	0.000161	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HADHB—breast cancer	2.31e-06	0.000161	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.29e-06	0.000161	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP17A1—breast cancer	2.26e-06	0.000158	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SYNJ2—breast cancer	2.26e-06	0.000158	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	2.26e-06	0.000158	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	2.25e-06	0.000158	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS1—breast cancer	2.24e-06	0.000157	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ENO1—breast cancer	2.24e-06	0.000157	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	2.23e-06	0.000156	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALDH1A1—breast cancer	2.2e-06	0.000154	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALDH7A1—breast cancer	2.2e-06	0.000154	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2D6—breast cancer	2.2e-06	0.000154	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	2.18e-06	0.000153	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	2.18e-06	0.000152	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOA2—breast cancer	2.16e-06	0.000151	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	2.13e-06	0.000149	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UMPS—breast cancer	2.11e-06	0.000148	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PHGDH—breast cancer	2.11e-06	0.000148	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NME1—breast cancer	2.11e-06	0.000148	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ADSL—breast cancer	2.11e-06	0.000148	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FHL2—breast cancer	2.11e-06	0.000148	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NDUFS3—breast cancer	2.1e-06	0.000147	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	2.1e-06	0.000147	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ALB—breast cancer	2.1e-06	0.000147	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—FASN—breast cancer	2.09e-06	0.000146	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—BCHE—breast cancer	2.08e-06	0.000146	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LDHB—breast cancer	2.07e-06	0.000145	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HPSE—breast cancer	2.07e-06	0.000145	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—BRIP1—breast cancer	2.07e-06	0.000145	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC5A5—breast cancer	2.06e-06	0.000144	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	2.04e-06	0.000143	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	2.02e-06	0.000141	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NQO1—breast cancer	1.99e-06	0.000139	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC2A1—breast cancer	1.99e-06	0.000139	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CHST9—breast cancer	1.98e-06	0.000138	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.97e-06	0.000138	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCC1—breast cancer	1.96e-06	0.000137	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA3—breast cancer	1.96e-06	0.000137	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMMR—breast cancer	1.96e-06	0.000137	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP3A4—breast cancer	1.94e-06	0.000136	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1B1—breast cancer	1.91e-06	0.000133	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARGC1B—breast cancer	1.9e-06	0.000133	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—RAF1—breast cancer	1.9e-06	0.000133	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.89e-06	0.000132	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—COX11—breast cancer	1.87e-06	0.000131	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HSP90AA1—breast cancer	1.87e-06	0.000131	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.86e-06	0.00013	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOA1—breast cancer	1.82e-06	0.000127	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.81e-06	0.000127	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.8e-06	0.000126	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA4—breast cancer	1.79e-06	0.000126	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA9—breast cancer	1.79e-06	0.000126	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—STK11—breast cancer	1.79e-06	0.000125	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP19A1—breast cancer	1.79e-06	0.000125	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.77e-06	0.000124	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA2—breast cancer	1.75e-06	0.000122	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPX2—breast cancer	1.75e-06	0.000122	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPX4—breast cancer	1.73e-06	0.000121	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SULT1A1—breast cancer	1.73e-06	0.000121	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SHMT1—breast cancer	1.71e-06	0.00012	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CDA—breast cancer	1.71e-06	0.00012	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA1—breast cancer	1.69e-06	0.000118	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—IDH1—breast cancer	1.69e-06	0.000118	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.69e-06	0.000118	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.67e-06	0.000117	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NAT2—breast cancer	1.67e-06	0.000117	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—COMT—breast cancer	1.67e-06	0.000117	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTP1—breast cancer	1.66e-06	0.000116	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.65e-06	0.000116	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC2A5—breast cancer	1.65e-06	0.000116	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMOX1—breast cancer	1.63e-06	0.000114	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ITPR1—breast cancer	1.63e-06	0.000114	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APRT—breast cancer	1.59e-06	0.000112	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCB1—breast cancer	1.57e-06	0.00011	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TYMS—breast cancer	1.54e-06	0.000108	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.54e-06	0.000107	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOR1—breast cancer	1.52e-06	0.000107	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTM1—breast cancer	1.52e-06	0.000107	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLA2G4A—breast cancer	1.52e-06	0.000107	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ESRRA—breast cancer	1.5e-06	0.000105	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.5e-06	0.000105	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.49e-06	0.000104	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—DPYD—breast cancer	1.46e-06	0.000102	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MED12—breast cancer	1.46e-06	0.000102	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GPX1—breast cancer	1.46e-06	0.000102	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1A1—breast cancer	1.44e-06	0.000101	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALDOA—breast cancer	1.44e-06	0.000101	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ERCC2—breast cancer	1.43e-06	0.0001	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HADHB—breast cancer	1.42e-06	9.94e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPI—breast cancer	1.42e-06	9.94e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOA3—breast cancer	1.4e-06	9.78e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC2A2—breast cancer	1.39e-06	9.71e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCG2—breast cancer	1.36e-06	9.51e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTR—breast cancer	1.36e-06	9.51e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CPT1A—breast cancer	1.36e-06	9.51e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.36e-06	9.49e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.36e-06	9.49e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—breast cancer	1.35e-06	9.42e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HPGDS—breast cancer	1.33e-06	9.33e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HBA1—breast cancer	1.32e-06	9.27e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FHL2—breast cancer	1.3e-06	9.09e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NME1—breast cancer	1.3e-06	9.09e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADSL—breast cancer	1.3e-06	9.09e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UMPS—breast cancer	1.3e-06	9.09e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PHGDH—breast cancer	1.3e-06	9.09e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ACHE—breast cancer	1.29e-06	9.05e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTT1—breast cancer	1.29e-06	9.05e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BRIP1—breast cancer	1.27e-06	8.92e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HPSE—breast cancer	1.27e-06	8.92e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LDHB—breast cancer	1.27e-06	8.92e-05	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.25e-06	8.78e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAV1—breast cancer	1.24e-06	8.69e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP17A1—breast cancer	1.22e-06	8.56e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ENO1—breast cancer	1.21e-06	8.48e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS1—breast cancer	1.21e-06	8.48e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMMR—breast cancer	1.21e-06	8.45e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCC1—breast cancer	1.21e-06	8.45e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA3—breast cancer	1.21e-06	8.45e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2D6—breast cancer	1.19e-06	8.31e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.17e-06	8.19e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOA2—breast cancer	1.17e-06	8.16e-05	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.13e-06	7.93e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FASN—breast cancer	1.13e-06	7.91e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CG—breast cancer	1.13e-06	7.91e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—BCHE—breast cancer	1.13e-06	7.88e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC5A5—breast cancer	1.11e-06	7.79e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA9—breast cancer	1.1e-06	7.73e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA4—breast cancer	1.1e-06	7.73e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA2—breast cancer	1.08e-06	7.54e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPX2—breast cancer	1.08e-06	7.54e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NQO1—breast cancer	1.07e-06	7.52e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC2A1—breast cancer	1.07e-06	7.52e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPX4—breast cancer	1.06e-06	7.44e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SULT1A1—breast cancer	1.06e-06	7.44e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP3A4—breast cancer	1.05e-06	7.33e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA1—breast cancer	1.04e-06	7.27e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—IDH1—breast cancer	1.04e-06	7.27e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1B1—breast cancer	1.03e-06	7.21e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NAT2—breast cancer	1.03e-06	7.19e-05	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.02e-06	7.17e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSP90AA1—breast cancer	1.01e-06	7.07e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CD—breast cancer	9.94e-07	6.96e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOA1—breast cancer	9.83e-07	6.88e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALB—breast cancer	9.81e-07	6.87e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—STK11—breast cancer	9.68e-07	6.78e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP19A1—breast cancer	9.68e-07	6.78e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NOS3—breast cancer	9.39e-07	6.57e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MED12—breast cancer	9.01e-07	6.3e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—DPYD—breast cancer	9.01e-07	6.3e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—COMT—breast cancer	9e-07	6.3e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTP1—breast cancer	8.96e-07	6.27e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALDOA—breast cancer	8.87e-07	6.21e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMOX1—breast cancer	8.84e-07	6.18e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ITPR1—breast cancer	8.82e-07	6.17e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CB—breast cancer	8.67e-07	6.06e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOA3—breast cancer	8.61e-07	6.02e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—breast cancer	8.59e-07	6.01e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC2A2—breast cancer	8.55e-07	5.98e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CPT1A—breast cancer	8.37e-07	5.86e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCG2—breast cancer	8.37e-07	5.86e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTR—breast cancer	8.37e-07	5.86e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TYMS—breast cancer	8.33e-07	5.83e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM1—breast cancer	8.23e-07	5.76e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOR1—breast cancer	8.23e-07	5.76e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLA2G4A—breast cancer	8.23e-07	5.76e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HPGDS—breast cancer	8.21e-07	5.75e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HBA1—breast cancer	8.16e-07	5.71e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ACHE—breast cancer	7.97e-07	5.57e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTT1—breast cancer	7.97e-07	5.57e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPX1—breast cancer	7.89e-07	5.52e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1A1—breast cancer	7.81e-07	5.46e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ERCC2—breast cancer	7.74e-07	5.42e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP17A1—breast cancer	7.54e-07	5.28e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—breast cancer	7.49e-07	5.24e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS1—breast cancer	7.46e-07	5.22e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ENO1—breast cancer	7.46e-07	5.22e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2D6—breast cancer	7.32e-07	5.12e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—breast cancer	7.28e-07	5.09e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOA2—breast cancer	7.18e-07	5.03e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FASN—breast cancer	6.97e-07	4.88e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BCHE—breast cancer	6.94e-07	4.86e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC5A5—breast cancer	6.85e-07	4.8e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAV1—breast cancer	6.71e-07	4.7e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC2A1—breast cancer	6.62e-07	4.63e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NQO1—breast cancer	6.62e-07	4.63e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1B1—breast cancer	6.35e-07	4.44e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSP90AA1—breast cancer	6.22e-07	4.36e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CG—breast cancer	6.11e-07	4.28e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOA1—breast cancer	6.05e-07	4.24e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP19A1—breast cancer	5.97e-07	4.18e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—STK11—breast cancer	5.97e-07	4.18e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—COMT—breast cancer	5.55e-07	3.88e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTP1—breast cancer	5.52e-07	3.86e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMOX1—breast cancer	5.44e-07	3.81e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ITPR1—breast cancer	5.43e-07	3.8e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CD—breast cancer	5.38e-07	3.76e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALB—breast cancer	5.31e-07	3.71e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—breast cancer	5.28e-07	3.7e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCB1—breast cancer	5.23e-07	3.66e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TYMS—breast cancer	5.13e-07	3.59e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NOS3—breast cancer	5.08e-07	3.55e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM1—breast cancer	5.07e-07	3.55e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLA2G4A—breast cancer	5.07e-07	3.55e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOR1—breast cancer	5.07e-07	3.55e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPX1—breast cancer	4.86e-07	3.4e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1A1—breast cancer	4.81e-07	3.37e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ERCC2—breast cancer	4.77e-07	3.34e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CB—breast cancer	4.69e-07	3.28e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—breast cancer	4.64e-07	3.25e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—breast cancer	4.48e-07	3.14e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—breast cancer	4.32e-07	3.02e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAV1—breast cancer	4.14e-07	2.89e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—breast cancer	4.05e-07	2.83e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CG—breast cancer	3.77e-07	2.64e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CD—breast cancer	3.31e-07	2.32e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALB—breast cancer	3.27e-07	2.29e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NOS3—breast cancer	3.13e-07	2.19e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CB—breast cancer	2.89e-07	2.02e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—breast cancer	2.86e-07	2e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—breast cancer	2.86e-07	2e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—breast cancer	2.49e-07	1.75e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—breast cancer	2.33e-07	1.63e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—breast cancer	1.76e-07	1.23e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—breast cancer	1.44e-07	1.01e-05	CbGpPWpGaD
